Clinical trialNCT05771675RecruitingEarly phase 1Interventional

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

SponsorCedars-Sinai Medical CenterEnrollment90Chronic PancreatitisRecurrent Acute Pancreatitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this pilot study to examine the feasibility and acceptability of simvastatin in adults with Recurrent Acute Pancreatitis (RAP) and Chronic Pancreatitis (CP).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Stephen Pandol, MD
Cedars-Sinai Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Cedars-Sinai Medical Center
Los Angeles, California, United States
Stephen Pandol, MD
Recruiting
University of Southern California
Los Angeles, California, United States
James Buxbaum, MD
Recruiting
Stanford University
Stanford, California, United States
Walter Park, MD
Recruiting
Ohio State University
Columbus, Ohio, United States
Georgios Papachristou, MD
Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Dhiraj Yadav, MD, MPH
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboSimvastatin →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 24 Oct 2024
Primary completion: 31 Dec 2027
Completion: 30 Jun 2028
Last update posted: 5 Aug 2026
Registered enrollment: 90
Registry id: NCT05771675

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.